Baxter International (BAX) Net Income towards Common Stockholders (2009 - 2026)

Baxter International (BAX) reported Net Income towards Common Stockholders of $2.0 million for Q1 2026, down 96.77% year-over-year from $62.0 million in Q1 2025, and up 102.15% quarter-over-quarter from -$93.0 million in Q4 2025.

Baxter International (BAX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Baxter International (BAX) has 18 years of Net Income towards Common Stockholders data on file, last reported at $2.0 million in Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at $2.0 million, down 96.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$117.0 million (up 58.66% YoY), and the FY2025 annual result was -$57.0 million, up 81.73% from the prior year.
  • Net Income towards Common Stockholders advanced to $2.0 million in Q1 2026 per BAX's latest filing, from -$93.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $2.5 billion in Q3 2023 and troughed at -$406.0 million in Q2 2024.
  • A 5-year average of $138.1 million and a median of $33.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders soared 4240.35% in 2023, then plunged 322.73% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $41.0 million in 2022, then tumbled by 34.15% to $27.0 million in 2023, then sank by 181.48% to -$22.0 million in 2024, then slumped by 322.73% to -$93.0 million in 2025, then surged by 102.15% to $2.0 million in 2026.
  • Business Quant data shows BAX's Net Income towards Common Stockholders at $2.0 million in Q1 2026, -$93.0 million in Q4 2025, and $5.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -274.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 239.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 398.73 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 135.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 13.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -77.90 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 112.77 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 2.00 Mn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn 72.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00 Mn
Dec 31, 2025 -93.00 Mn
Sep 30, 2025 5.00 Mn
Jun 30, 2025 -31.00 Mn
Mar 31, 2025 62.00 Mn
Dec 31, 2024 -22.00 Mn
Sep 30, 2024 83.00 Mn
Jun 30, 2024 -406.00 Mn
Mar 31, 2024 33.00 Mn
Dec 31, 2023 27.00 Mn
Sep 30, 2023 2.47 Bn
Jun 30, 2023 -112.00 Mn
Mar 31, 2023 93.00 Mn
Dec 31, 2022 41.00 Mn
Sep 30, 2022 57.00 Mn
Jun 30, 2022 70.00 Mn
Mar 31, 2022 65.00 Mn
Dec 31, 2021 -20.00 Mn
Sep 30, 2021 452.00 Mn
Jun 30, 2021 301.00 Mn